U.K. IT Stock News

LSE:AZN
LSE:AZNPharmaceuticals

Is AstraZeneca (LSE:AZN) Still Sensibly Priced After A 31.3% One Year Share Gain

If you are wondering whether AstraZeneca shares are still priced sensibly after a strong run, this article walks through what the current market price might be implying about value. The stock last closed at £140.52, with a 1.2% decline over 7 days, a 3.7% return over 30 days, a 3.4% return year to date, and a 31.3% return over 1 year, which may influence how investors see its balance of opportunity and risk. Recent news around AstraZeneca has focused on its broad pharmaceutical portfolio and...
LSE:DGE
LSE:DGEBeverage

Is Diageo (LSE:DGE) Offering An Opportunity After A 29.1% One-Year Share Price Slide

If you are wondering whether Diageo shares offer good value at today’s price, this article will walk through what the numbers are saying and how that might fit with your own expectations. The stock is trading at £16.56 after a mixed run, with a 1.6% gain over the last week, a 1.4% decline over the past month, a 3.0% gain year to date, and a 29.1% decline over the last year that adds important context for long term holders. That share price path sits alongside ongoing news flow around the...
LSE:GSK
LSE:GSKPharmaceuticals

Is GSK (LSE:GSK) Pricing Look Attractive After Strong Multi Year Share Gains?

If you are wondering whether GSK is still offering value after its recent strength, you are not alone. This article will walk through what the current price might be implying. The share price closed at £18.17, with a 3.7% decline over the past week, a 0.9% decline over 30 days, a 0.8% decline year to date, and returns of 39.5% over 1 year, 45.7% over 3 years and 62.7% over 5 years. Recent market attention on GSK has been influenced by ongoing product developments, regulatory decisions and...
AIM:IOF
AIM:IOFChemicals

3 UK Penny Stocks With Market Caps Under £70M

The United Kingdom's FTSE 100 index has recently experienced a downturn, influenced by weak trade data from China and its ongoing struggle to recover from the pandemic. Despite these broader market challenges, penny stocks continue to capture investor interest due to their potential for growth and value. Although the term "penny stocks" may seem outdated, these smaller or newer companies can still present compelling opportunities when supported by robust financials.